Show simple item record

dc.contributor.authorStreeten, E.A.
dc.date.accessioned2019-09-19T18:35:44Z
dc.date.available2019-09-19T18:35:44Z
dc.date.issued2017
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85044468609&doi=10.1210%2fjc.2017-01346&partnerID=40&md5=df3245b4c046287846941e5984ba0daa
dc.identifier.urihttp://hdl.handle.net/10713/10932
dc.description.urihttps://doi.org/10.1210/jc.2017-01346en_US
dc.language.isoen_USen_US
dc.publisherOxford University Pressen_US
dc.relation.ispartofJournal of Clinical Endocrinology and Metabolism
dc.subjectVitamin D2en_US
dc.subject.meshHypoparathyroidismen_US
dc.subject.meshErgocalciferolsen_US
dc.subject.meshHypocalcemiaen_US
dc.subject.meshCalcitriolen_US
dc.subject.meshTreatment Adherence and Complianceen_US
dc.titleResponse to letter: "Hypoparathyroidism: less severe hypocalcemia with treatment with vitamin D2 compared with calcitriol"en_US
dc.typeArticleen_US
dc.identifier.doi10.1210/jc.2017-01346
dc.identifier.pmid28911162


This item appears in the following Collection(s)

Show simple item record